1 / 11

Branded Generics Market Analysis Will Expand at a CAGR of 7.3% from 2016-2026

Future Market Insights has announced the addition of the “Branded Generics Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.

pradnyavirkar
Télécharger la présentation

Branded Generics Market Analysis Will Expand at a CAGR of 7.3% from 2016-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Branded Generics Market: Global Industry Analysis and Opportunity Assessment 2016-2026 May 2017 Report Id : REP-GB-1260 Status : Jan-2017 Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved

  2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research ©2015 Future Market Insights, All Rights Reserved 2

  3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 PMR formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 PMR conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 PMR delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3

  4. Branded Generics Market Global Sales of Branded Generics Will Amass More Than US$ 400 Billion in Revenues By 2026-End A recent research conducted by Future Market Insights predicts that the global market for branded generics will witness a steady growth in terms of revenues. Over a ten-year forecast period from 2016 to 2026, the size of global branded generics market has been estimated to expand at a steady CAGR of 7.3%. Brand-name prescriptions will continue to be ubiquitous among aged people in the world, and since geriatric demographics account for a large portion of global drug-consuming population, demand for branded generics will also rise substantially. In 2016, the global branded generics market has been valued at nearly US$ 200 billion, and is projected to reach US$ 413.8 Bn market value by the end of forecast period. Some of the leading manufacturers of branded generics are based in Asian countries, and are extending their production capacity to keep up with the surging global depend. In Asia-Pacific excluding Japan (APEJ) region, about US$ 150 billion revenues are expected to be procured by the end of 2026. During the forecast period, branded generics market in the APEJ region will attain fastest growth, registering a 10% CAGR, contributing over 35% of global branded generics revenues. North America, Eastern Europe and Latin America are also expected to be lucrative for growth of branded generics sales, while revenues in Western Europe, Japan and Middle East & Africa (MEA) are likely to incur a considerable dip by 2026- end. ©2015 Future Market Insights, All Rights Reserved 4

  5. Branded Generics Market Competitive Timeline in Global Branded Generics Market  Since 2015, Abbott Laboratories, a leading drugmaker in the global pharmaceuticals industry, has aimed at capitalizing from branded generics businesses in developing regions.  Teva Pharmaceuticals acquired Allergan’s branded generics vertical, while Pfizer Inc. bought Hospira Inc. – both acquisitions have been strategically carried out for repositioning market standings of Teva and Pfizer respectively.  In December 2016, India-based Sun Pharmaceuticals Industries Ltd. agreed to buy Swiss drugmaker Novartis AG’s branded generics portfolio on cancer medications.  Another leading branded generics manufacturer, Mylan N.V. recently launched anti-allergy devices which are expected to be half the price of its branded EpiPens.  Other prominent companies partaking in the growth of global branded generics market include, Aspen Pharmacare Holding Ltd. and Valeant Pharmaceuticals International, Inc. Research Highlights on Global Branded Generics Market The report includes a segmental analysis of the global branded generics market, fragmenting its growth on the type of drug formulation, major drug classes, therapeutic applications, and distribution channels. ©2015 Future Market Insights, All Rights Reserved 5

  6. Branded Generics Market Based on such segmentation, some of the key findings compiled in the report are:  Nearly three-fifth of the global branded generics revenues estimated in 2016 are expected to be accounted by oral-type formulations, with parenteral, topic and other formulation types collectively accounting for 8% market value share.  Hospital pharmacies & retail pharmacies will remain as the largest distribution channels for branded generics throughout the globe.  In 2016 and beyond, the demand for branded generics in therapeutic treatment of cardiovascular diseases will be significant, revenues from which are expected to increase at more than 8% CAGR over the forecast period.  Global revenues of branded generics accounted by anti-hypertensive drug class are predicted to surpass US$ 25 billion by 2026-end. ©2015 Future Market Insights, All Rights Reserved 6

  7. Table of Content 1. Executive Summary 2. Market Introduction 2.1. Market Definition 2.2. Market Taxonomy 2.3. Generics Market Overview 3. Global Branded Generics Market Analysis Scenario 3.1. Market Size (US$ Mn) and Forecast 3.1.1. Market Size and Y-o-Y Growth 3.1.2. Absolute $ Opportunity 3.2. Market Overview 3.2.1. Value Chain 4. Market Dynamics 4.1. Macro-economic Factors 4.2. Drivers 4.2.1. Supply Side 4.2.2. Demand Side ©2015 Future Market Insights, All Rights Reserved 7

  8. Table of Content 4.3. Restraints 4.4. Opportunity 4.5. Forecast Factors – Relevance and Impact 4.7.Regulations 4.8.Porter Five Forces Model 4.9.Patennt expiries in 2016 5. Global Branded Generics Market Analysis and Forecasts, By Therapeutic Application Type 5.1. Introduction 5.2. Basis Point Share (BPS) Analysis By Therapeutic Application Type 5.3. Y-o-Y Growth Projections By Therapeutic Application Type 5.4. Market Value Forecast By Therapeutic Application Type , 2016–2026 5.4.1. Oncology 5.4.2. Cardiovascular Diseases 5.4.3. Diabetes 5.4.4. Neurology 5.4.5. Gastrointestinal Diseases 5.4.6. Dermatology Dieases 5.4.7. Analgesics and Anti-inflammatory 5.4.8. Others ©2015 Future Market Insights, All Rights Reserved 8

  9. Table of Content 5.5. Prominent Trends 5.6. Market Attractiveness By Therapeutic Application Type 6. Global Branded Generics Market Analysis and Forecasts, By Distribution Channel 6.1. Introduction 6.2. Basis Point Share (BPS) Analysis By Distribution Channel 6.3. Y-o-Y Growth Projections By Distribution Channel 6.4. Market Value Forecast By Distribution Channel, 2016–2026 6.4.1. Hospital Pharmacies 6.4.2. Retail Pharmacies 6.4.3. Online Pharmacies 6.4.4. Drug Stores 6.5. Prominent Trends 6.6. Market Attractiveness By Distribution Channel 7. Global Branded Generics Market Analysis and Forecasts, By Major Drug Classes 7.1. Introduction 7.2. Basis Point Share (BPS) Analysis By Major Drug Classes 7.3. Y-o-Y Growth Projections By Major Drug Classes 7.4. Market Value Forecast By Major Drug Classes, 2016–2026 7.4.1. Alkylating Agents ©2015 Future Market Insights, All Rights Reserved 9

  10. Table of Content 7.4.2. Antimetabolites 7.4.3. Hormones 7.4.4. Anti-Hypertensive 7.4.5. Lipid Lowering Drugs 7.4.6. Anti-Depressants 7.4.7. Anti-Psychotics 7.4.8. Anti-Epileptic 7.4.9. Others 7.5. Prominent Trends 7.6. Market Attractiveness By Major Drug Classes 8. Global Branded Generics Market Analysis and Forecasts, By Formulation Type 8.1. Introduction 8.2. Basis Point Share (BPS) Analysis By Formulation Type 8.3. Y-o-Y Growth Projections By Formulation Type 8.4. Market Value Forecast By Formulation Type , 2016–2026 8.4.1. Oral 8.4.2. Parenteral 8.4.3. Topical 8.4.4. Others 8.5. Prominent Trends 8.6. Market Attractiveness By Formulation Type ©2015 Future Market Insights, All Rights Reserved 10

  11. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You ©2015 Future Market Insights, All Rights Reserved 11

More Related